SEC Form 4 · accession 0001209191-18-047401
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Andrew Smith
Director
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.34 | Aug 15, 2018 | A | 11,000 | A | — | Aug 14, 2028 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1This option was granted on August 15, 2018, with the shares subject to the option vesting over a three year period from the date of grant in 36 equal monthly installments.